Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


“Wonder Drugs” Continue On India Market Due To Lax Laws

This article was originally published in PharmAsia News

Executive Summary

Supplements and other products touted as wonder drugs to cure most major diseases continue to be sold in India because of lax laws controlling the industry. A physician complained the country has no laws allowing regulation of food and dietary supplements, so claims for therapies for complicated diseases go unchallenged. India has its Drugs and Magic Remedies Act, but it is rarely enforced even though drug regulators have the authority to act against misleading advertisements. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts